These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 471084)

  • 21. [HBs and HBc antigens in the liver of patients with chronic liver diseases].
    Jabłońska-Kaszewska I; Bielawski W; Zółtowska A; Zamorska I; Fenc E
    Pol Tyg Lek; 1982 Jun; 37(19-20):541-4. PubMed ID: 7177943
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatitis and hepatitis B surface antigen and antibody in dentists.
    Berris B; Feinman SV; Sinclair JC; Wrobel D
    Can Med Assoc J; 1978 Nov; 119(9):1040-3. PubMed ID: 743666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunohistochemical study of hepatitis B and D virus antigens (HBsAg, HBcAg, HDAg) in chronic liver diseases].
    Horváth G; Stotz G; Schaff Z; Tolvaj G; Dávid K
    Orv Hetil; 1996 May; 137(21):1133-8. PubMed ID: 8757107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic active hepatitis in hepatitis B surface antigen (HBsAg) carriers. The need for liver biopsy.
    Sampliner R
    JAMA; 1977 Jan; 237(1):50-1. PubMed ID: 576131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Behavior and clinical significance of the eAg/ anti-e system in carriers of HBsAg].
    Pastore G; Dentico P; Fera G; Angarano G; Schiraldi O
    Boll Ist Sieroter Milan; 1977 Sep; 56(4):333-8. PubMed ID: 911461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparative analysis of blood donors with antibodies to the hepatitis C virus, positivity for the hepatitis B surface antigen and hypertransaminasemia in Asturias].
    Suárez A; Riestra S; Rodríguez M; Linares A; Otero L; Rodrigo L
    Med Clin (Barc); 1994 Jul; 103(6):209-13. PubMed ID: 7967864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytogenic analysis in HBsAg positive subjects, healthy carriers and patients with acute-phase hepatitis].
    Vianello MG; Fasce LC; Mura MS; Andreoni G; Scalise G
    Boll Ist Sieroter Milan; 1979 Jul; 58(3):266-72. PubMed ID: 518760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HLA antigens in blood donors, asymptomatic chronic carriers of the viral hepatitis type B surface antigen (HBsAg)].
    Morales VH; Barbetti A; Basualdo JA; Jmelnitzky A; Landoni N; Ponce de León H; Chopita N; de Torres RA
    Medicina (B Aires); 1983; 43(2):175-80. PubMed ID: 6664285
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis B surface antigen carriers--to biopsy or not to biopsy.
    Koretz RL; Lewin KJ; Rebhun DJ; Gitnick GL
    Gastroenterology; 1978 Nov; 75(5):860-3. PubMed ID: 700327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic histology in chronic liver disease in hepatitis B surface antigen positive cases.
    Ghosh AK; Dasgupta A; Raha K; Jana A; Majumdar DN
    J Indian Med Assoc; 1994 Oct; 92(10):333-5. PubMed ID: 7822848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 33. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic liver findings in Australia antigen (Au-ag) positive blood donors].
    Wagner K; Theuer D; Hecht A; Surber H; Blauärmel O; Schimmelpfennig W; Schneider G
    Dtsch Gesundheitsw; 1971 Oct; 26(43):2010-2. PubMed ID: 5144072
    [No Abstract]   [Full Text] [Related]  

  • 35. [The prognostic significance of quantitative HBsAG determination in acute hepatitis B].
    Joller-Jemelka HI; Pfister HF; Grob PJ
    Schweiz Med Wochenschr; 1985 Sep; 115(37):1249-56. PubMed ID: 3903984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part II: Evaluation of epidemiological factors and suspected risk factors of liver dysfunction.
    Shiina S; Fujino H; Kawabe T; Tagawa K; Unuma T; Yoneyama M; Ohmori T; Suzuki S; Kurita M; Ohashi Y
    Am J Gastroenterol; 1991 Jul; 86(7):872-5. PubMed ID: 2058630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers.
    Anh-Tuan N; Novák E
    Clin Exp Immunol; 1981 Feb; 43(2):246-53. PubMed ID: 7273479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prospective study of chronic asymptomatic carriers of hepatitis B surface antigen].
    Velasco M; Katz R; Puelma E; Brahm J; González M; Donoso S
    Rev Med Chil; 1984 Feb; 112(2):115-20. PubMed ID: 6740018
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevalence of the surface antigen of the hepatitis type B virus (HBsAg) in chronic hepatic disease].
    Ocaña Andrade E; Valverde Castañeda N; Garrido Palma J; Carrillo Cambero JL
    Rev Gastroenterol Mex; 1985; 50(1):19-22. PubMed ID: 4089439
    [No Abstract]   [Full Text] [Related]  

  • 40. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G; Günalp A
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.